Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Accuracy of Vitalograph lung monitor as a screening test for COPD in primary care.

Dickens AP, Fitzmaurice DA, Adab P, Sitch A, Riley RD, Enocson A, Jordan RE.

NPJ Prim Care Respir Med. 2020 Jan 3;30(1):2. doi: 10.1038/s41533-019-0158-2.

2.

Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.

Hacke W, Bassand JP, Virdone S, Camm AJ, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AG, van Eickels M, Verheugt FW, Kakkar AK; GARFIELD-AF Investigators.

Int J Stroke. 2019 Dec 17:1747493019891516. doi: 10.1177/1747493019891516. [Epub ahead of print]

PMID:
31847794
3.

New AI Prediction Model Using Serial PT-INR Measurements in AF Patients on VKAs: GARFIELD-AF.

Goto S, Goto S, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Haas S, Parkhomenko A, Oto A, Misselwitz F, Turpie AGG, Verheugt FWA, Fox KAA, Gersh BJ, Kakkar AK; GARFIELD-AF Investigators.

Eur Heart J Cardiovasc Pharmacother. 2019 Dec 10. pii: pvz076. doi: 10.1093/ehjcvp/pvz076. [Epub ahead of print]

PMID:
31821482
4.

Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.

Lowres N, Olivier J, Chao TF, Chen SA, Chen Y, Diederichsen A, Fitzmaurice DA, Gomez-Doblas JJ, Harbison J, Healey JS, Hobbs FDR, Kaasenbrood F, Keen W, Lee VW, Lindholt JS, Lip GYH, Mairesse GH, Mant J, Martin JW, Martín-Rioboó E, McManus DD, Muñiz J, Münzel T, Nakamya J, Neubeck L, Orchard JJ, Pérula de Torres LÁ, Proietti M, Quinn FR, Roalfe AK, Sandhu RK, Schnabel RB, Smyth B, Soni A, Tieleman R, Wang J, Wild PS, Yan BP, Freedman B.

PLoS Med. 2019 Sep 25;16(9):e1002903. doi: 10.1371/journal.pmed.1002903. eCollection 2019 Sep.

5.

Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.

Verheugt FWA, Ambrosio G, Atar D, Bassand JP, Camm AJ, Costabel JP, Fitzmaurice DA, Illingworth L, Goldhaber SZ, Goto S, Haas S, Jansky P, Kayani G, Stepinska J, Turpie AGG, van Eickels M, Kakkar AK; GARFIELD-AF Investigators.

Am J Med. 2019 Dec;132(12):1431-1440.e7. doi: 10.1016/j.amjmed.2019.06.008. Epub 2019 Jul 12.

PMID:
31306621
6.

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.

Corbalan R, Bassand JP, Illingworth L, Ambrosio G, Camm AJ, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Haas S, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

JAMA Cardiol. 2019 Jun 1;4(6):526-548. doi: 10.1001/jamacardio.2018.4729.

PMID:
31066873
7.

Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.

Bassand JP, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox KAA, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK.

Circulation. 2019 Feb 5;139(6):787-798. doi: 10.1161/CIRCULATIONAHA.118.035012.

PMID:
30586740
8.

Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.

Miller MR, Haroon S, Jordan RE, Sitch AJ, Dickens AP, Enocson A, Fitzmaurice DA, Adab P.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 21;13:1979-1986. doi: 10.2147/COPD.S146914. eCollection 2018.

9.

Case-finding for COPD in primary care: a qualitative study of patients' perspectives.

Enocson A, Jolly K, Jordan RE, Fitzmaurice DA, Greenfield SM, Adab P.

Int J Chron Obstruct Pulmon Dis. 2018 May 17;13:1623-1632. doi: 10.2147/COPD.S147718. eCollection 2018.

10.
11.

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.

Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, Fox KAA, Gao H, Goldhaber SZ, Goto S, Haas S, Kayani G, Pieper K, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

PLoS One. 2018 Jan 25;13(1):e0191592. doi: 10.1371/journal.pone.0191592. eCollection 2018.

12.

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.

Apenteng PN, Gao H, Hobbs FR, Fitzmaurice DA; UK GARFIELD-AF Investigators and GARFIELD-AF Steering Committee.

BMJ Open. 2018 Jan 13;8(1):e018905. doi: 10.1136/bmjopen-2017-018905.

13.

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.

Fox KAA, Lucas JE, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Oto A, Mantovani LG, Misselwitz F, Piccini JP, Turpie AGG, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

BMJ Open. 2017 Dec 21;7(12):e017157. doi: 10.1136/bmjopen-2017-017157.

14.

Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice.

Fay MR, Fitzmaurice DA, Freedman B.

Eur J Gen Pract. 2017 Dec;23(1):246-253. doi: 10.1080/13814788.2017.1374366. Review.

PMID:
29034749
15.

Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Fox KAA, Accetta G, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Kayani G, Kakkar AK; GARFIELD-AF Investigators.

Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):27-35. doi: 10.1093/ehjqcco/qcx030.

PMID:
28950344
16.

Factors associated with work productivity among people with COPD: Birmingham COPD Cohort.

Rai KK, Adab P, Ayres JG, Siebert WS, Sadhra SS, Sitch AJ, Fitzmaurice DA, Jordan RE; BLISS research team*.

Occup Environ Med. 2017 Dec;74(12):859-867. doi: 10.1136/oemed-2016-104014. Epub 2017 Sep 12.

PMID:
28899966
17.

An evaluation of a coagulation system (Xprecia Stride) for utilisation in anticoagulation management.

McCahon D, Roalfe A, Fitzmaurice DA.

J Clin Pathol. 2018 Jan;71(1):20-26. doi: 10.1136/jclinpath-2017-204456. Epub 2017 Jun 13.

PMID:
28611189
18.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.

Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.

PMID:
28483832
19.

Barriers and enablers of physical activity engagement for patients with COPD in primary care.

Kosteli MC, Heneghan NR, Roskell C, Williams SE, Adab P, Dickens AP, Enocson A, Fitzmaurice DA, Jolly K, Jordan R, Greenfield S, Cumming J.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 28;12:1019-1031. doi: 10.2147/COPD.S119806. eCollection 2017.

20.

Birmingham COPD Cohort: a cross-sectional analysis of the factors associated with the likelihood of being in paid employment among people with COPD.

Rai KK, Jordan RE, Siebert WS, Sadhra SS, Fitzmaurice DA, Sitch AJ, Ayres JG, Adab P.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 11;12:233-242. doi: 10.2147/COPD.S119467. eCollection 2017.

21.

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, Corbalan R, Darius H, Fitzmaurice DA, Goldhaber SZ, Goto S, Jacobson B, Kayani G, Mantovani LG, Misselwitz F, Pieper K, Schellong SM, Stepinska J, Turpie AG, van Eickels M, Kakkar AK; GARFIELD-AF Investigators.

PLoS One. 2016 Oct 28;11(10):e0164076. doi: 10.1371/journal.pone.0164076. eCollection 2016.

22.

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.

Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E, Cools F, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Koretsune Y, Mantovani LG, Misselwitz F, Oh S, Turpie AG, Verheugt FW, Kakkar AK; GARFIELD-AF Investigators.

Heart. 2017 Feb 15;103(4):307-314. doi: 10.1136/heartjnl-2016-309832. Epub 2016 Sep 19.

23.

Cohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study.

Adab P, Fitzmaurice DA, Dickens AP, Ayres JG, Buni H, Cooper BG, Daley AJ, Enocson A, Greenfield S, Jolly K, Jowett S, Kalirai K, Marsh JL, Miller MR, Riley RD, Siebert WS, Stockley RA, Turner AM, Cheng KK, Jordan RE.

Int J Epidemiol. 2017 Feb 1;46(1):23. doi: 10.1093/ije/dyv350. No abstract available.

PMID:
27378796
24.

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.

Bassand JP, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Ten Cate H, Turpie AG, Verheugt FW, Kakkar AK; GARFIELD-AF Investigators.

Eur Heart J. 2016 Oct 7;37(38):2882-2889. Epub 2016 Jun 29.

25.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942
26.

Self-management of health care behaviors for COPD: a systematic review and meta-analysis.

Jolly K, Majothi S, Sitch AJ, Heneghan NR, Riley RD, Moore DJ, Bates EJ, Turner AM, Bayliss SE, Price MJ, Singh SJ, Adab P, Fitzmaurice DA, Jordan RE.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 17;11:305-26. doi: 10.2147/COPD.S90812. eCollection 2016. Review.

27.

Stroke prevention in atrial fibrillation: we can do better.

Kearney M, Fay M, Fitzmaurice DA.

Br J Gen Pract. 2016 Feb;66(643):62-3. doi: 10.3399/bjgp16X683557. No abstract available.

28.

Assessing the utility of an online registry for patients monitoring their own warfarin therapy.

McCahon D, Baker JM, Murray ET, Fitzmaurice DA.

J Clin Pathol. 2016 Apr;69(4):331-6. doi: 10.1136/jclinpath-2015-203168. Epub 2015 Oct 30.

PMID:
26519487
29.

General practice nursing: revisited and reinvigorated.

Fitzmaurice DA, Moger A, Storey K.

Br J Gen Pract. 2015 Oct;65(639):e636-7. doi: 10.3399/bjgp15X686785. No abstract available.

30.

Case finding for COPD in primary care: a qualitative study of the views of health professionals.

Haroon S, Jordan RE, Fitzmaurice DA, Adab P.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 28;10:1711-8. doi: 10.2147/COPD.S84247. eCollection 2015.

31.

Gods and Heroes.

Fitzmaurice DA.

Br J Gen Pract. 2015 Aug;65(637):423. doi: 10.3399/bjgp15X686257. No abstract available.

32.

Supported self-management for patients with COPD who have recently been discharged from hospital: a systematic review and meta-analysis.

Majothi S, Jolly K, Heneghan NR, Price MJ, Riley RD, Turner AM, Bayliss SE, Moore DJ, Singh SJ, Adab P, Fitzmaurice DA, Jordan RE.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 29;10:853-67. doi: 10.2147/COPD.S74162. eCollection 2015. Review.

33.

Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, Price MJ, Bates EJ, Turner AM, Bayliss S, Moore D, Singh S, Adab P, Fitzmaurice DA, Jowett S, Jolly K.

Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360. Review.

34.

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.

Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20. doi: 10.1161/CIRCOUTCOMES.114.001556. Epub 2015 Feb 24.

PMID:
25714828
35.

TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.

Jordan RE, Adab P, Jowett S, Marsh JL, Riley RD, Enocson A, Miller MR, Cooper BG, Turner AM, Ayres JG, Cheng KK, Jolly K, Stockley RA, Greenfield S, Siebert S, Daley A, Fitzmaurice DA.

BMC Pulm Med. 2014 Oct 4;14:157. doi: 10.1186/1471-2466-14-157.

36.

Research into practice: management of atrial fibrillation in general practice.

Fitzmaurice DA, Hobbs FD.

Br J Gen Pract. 2014 Oct;64(627):540-2. doi: 10.3399/bjgp14X682057. No abstract available.

37.

Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study.

Fitzmaurice DA, McCahon D, Baker J, Murray ET, Jowett S, Sandhar H, Holder RL, Hobbs FD.

Fam Pract. 2014 Jun;31(3):298-302. doi: 10.1093/fampra/cmu011. Epub 2014 Apr 12.

PMID:
24728774
38.

A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.

Smith JD, Baillie J, Baglin T, Griffiths GO, Casbard A, Cohen D, Fitzmaurice DA, Hood K, Rose P, Cohen AT, Johnson M, Maraveyas A, Bell J, Toone H, Nelson A, Noble SI.

Trials. 2014 Apr 12;15:122. doi: 10.1186/1745-6215-15-122.

39.

Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.

Holt TA, Fitzmaurice DA, Marshall T, Fay M, Qureshi N, Dalton AR, Hobbs FD, Lasserson DS, Kearley K, Hislop J, Jin J.

Trials. 2013 Nov 13;14:385. doi: 10.1186/1745-6215-14-385.

40.

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.

Ensor J, Riley RD, Moore D, Bayliss S, Jowett S, Fitzmaurice DA.

Syst Rev. 2013 Oct 3;2:91. doi: 10.1186/2046-4053-2-91.

41.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee.

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

42.

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Turpie AG, van Eickels M, Misselwitz F, Rushton-Smith S, Kayani G, Wilkinson P, Verheugt FW; GARFIELD Registry Investigators.

PLoS One. 2013 May 21;8(5):e63479. doi: 10.1371/journal.pone.0063479. Print 2013.

43.

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.

Apenteng PN, Murray ET, Holder R, Hobbs FD, Fitzmaurice DA; UK GARFIELD Investigators and GARFIELD Steering Committee.

BMC Cardiovasc Disord. 2013 Apr 23;13:31. doi: 10.1186/1471-2261-13-31.

44.

Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease.

Raichand S, Moore D, Riley RD, Lordkipanidzé M, Dretzke J, O'Donnell J, Jowett S, Bayliss S, Fitzmaurice DA.

Syst Rev. 2013 Feb 26;2:16. doi: 10.1186/2046-4053-2-16.

45.

Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years' experience.

Kitchen DP, Kitchen S, Jennings I, Woods TA, Fitzmaurice DA, Murray ET, Walker ID.

J Clin Pathol. 2012 Dec;65(12):1119-23. doi: 10.1136/jclinpath-2012-201049. Epub 2012 Oct 4.

PMID:
23038688
46.

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).

Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Verheugt FW, Jamal W, Misselwitz F, Rushton-Smith S, Turpie AG.

Am Heart J. 2012 Jan;163(1):13-19.e1. doi: 10.1016/j.ahj.2011.09.011. Epub 2011 Nov 20.

PMID:
22172431
47.

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.

Hobbs FD, Roalfe AK, Lip GY, Fletcher K, Fitzmaurice DA, Mant J; Birmingham Atrial Fibrillation in the Aged Investigators and Midland Research Practices Consortium Network.

BMJ. 2011 Jun 23;342:d3653. doi: 10.1136/bmj.d3653.

48.

Thromboembolism.

McManus RJ, Fitzmaurice DA, Murray E, Taylor C.

BMJ Clin Evid. 2011 Mar 8;2011. pii: 0208. Review.

49.

Does self-management of oral anticoagulation therapy improve quality of life and anxiety?

McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA.

Fam Pract. 2011 Apr;28(2):134-40. doi: 10.1093/fampra/cmq089. Epub 2010 Nov 10.

PMID:
21068191
50.

Point-of-care testing in haemostasis.

Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S.

Br J Haematol. 2010 Sep;150(5):501-14. doi: 10.1111/j.1365-2141.2010.08223.x. Epub 2010 Jul 7. Review.

PMID:
20618331

Supplemental Content

Loading ...
Support Center